Cargando…
The replicative senescent mesenchymal stem / stromal cells defect in DNA damage response and anti-oxidative capacity
Replicative senescence and potential malignant transformation are great limitations in the clinical application of bone marrow-derived mesenchymal stem / stromal cells (MSCs). An abnormal DNA damage response may result in genomic instability, which is an integral component of aging and tumorigenesis...
Autores principales: | Yu, Jin, Shi, Jiazhong, Zhang, Yue, Zhang, Yi, Huang, Yaqin, Chen, Zhiwen, Yang, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036081/ https://www.ncbi.nlm.nih.gov/pubmed/30008586 http://dx.doi.org/10.7150/ijms.24635 |
Ejemplares similares
-
Individual response to mTOR inhibition in delaying replicative senescence of mesenchymal stromal cells
por: Antonioli, Eliane, et al.
Publicado: (2019) -
Human mesenchymal stem cell-replicative senescence and oxidative stress are closely linked to aneuploidy
por: Estrada, J C, et al.
Publicado: (2013) -
Alteration of fatty acid oxidation by increased CPT1A on replicative senescence of placenta-derived mesenchymal stem cells
por: Seok, Jin, et al.
Publicado: (2020) -
Senescent mesenchymal stem/stromal cells and restoring their cellular functions
por: Meng, Qing-Shu, et al.
Publicado: (2020) -
Osteogenic differentiation of human mesenchymal stromal cells and fibroblasts differs depending on tissue origin and replicative senescence
por: Grotheer, Vera, et al.
Publicado: (2021)